White House Views Medicare Reform Plan

8 July 1997

Some proposed Medicare changes are not needed to balance the US budgetby 2002, White House budget director Franklin Raines has told the House and Senate budget panel chairmen. The moves should be seen as part of a bipartisan plan to deal with Medicare's long-term financing challenges, not part of the coming year's budget, he said.

The White House objects to Senate proposals such as gradually raising the eligibility age from 65 to 67 and linking Medicare premiums to family income, but agrees to setting up a commission to study Medicare's future. It also dislikes plans for Medicaid funding for disabled children losing their supplemental social security income due to new eligibility definitions, and expanding and extending a ban on using Medicaid money for abortions. The threat of a veto was not mentioned.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight